NCT00764465View on ClinicalTrials.gov

An Interaction Study to Assess Drug Levels in Healthy Adult Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Healthy
Interventions
DRUG

Maraviroc

300 mg BID

DRUG

Fosamprenavir

1400 mg BID, 700 mg BID or 1400 mg QD

DRUG

Ritonavir

100 mg BID, 100 mg QD

Trial Locations (1)

08043

Garden State Infectious Disease Associates,PA, Voorhees Township

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Garden State Infectious Disease Associates, PA

OTHER

NCT00764465 - An Interaction Study to Assess Drug Levels in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter